Cargando…

α-Ketoheterocycles Able to Inhibit the Generation of Prostaglandin E(2) (PGE(2)) in Rat Mesangial Cells

Prostaglandin E(2) (PGE(2)) is a key mediator of inflammation, and consequently huge efforts have been devoted to the development of novel agents able to regulate its formation. In this work, we present the synthesis of various α-ketoheterocycles and a study of their ability to inhibit the formation...

Descripción completa

Detalles Bibliográficos
Autores principales:	Psarra, Anastasia, Theodoropoulou, Maria A., Erhardt, Martin, Mertiri, Marina, Mantzourani, Christiana, Vasilakaki, Sofia, Magrioti, Victoria, Huwiler, Andrea, Kokotos, George
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7918003/ https://www.ncbi.nlm.nih.gov/pubmed/33668480 http://dx.doi.org/10.3390/biom11020275

Ejemplares similares

Small Peptides Able to Suppress Prostaglandin E(2) Generation in Renal Mesangial Cells
por: Vasilakaki, Sofia, et al.
Publicado: (2018)

N-Acylated and N-Alkylated 2-Aminobenzothiazoles Are Novel Agents That Suppress the Generation of Prostaglandin E(2)
por: Theodoropoulou, Maria A., et al.
Publicado: (2022)

Mammalian oocytes are targets for prostaglandin E2 (PGE2) action
por: Duffy, Diane M, et al.
Publicado: (2010)

Prostaglandin E2 (PGE2) and Roflumilast Involvement in IPF Progression
por: Moshkovitz, Noa, et al.
Publicado: (2023)

Development of a Liquid Chromatography–High Resolution Mass Spectrometry Method for the Determination of Free Fatty Acids in Milk
por: Kokotou, Maroula G., et al.
Publicado: (2020)

15‐Hydroperoxy‐PGE(2): Intermediate in Mammalian and Algal Prostaglandin Biosynthesis
por: Jagusch, Hans, et al.
Publicado: (2019)

Small-molecule inhibitors as potential therapeutics and as tools to understand the role of phospholipases A(2)()
por: Nikolaou, Aikaterini, et al.
Publicado: (2019)

The Wae to repair: prostaglandin E2 (PGE(2)) triggers intestinal wound repair
por: Jackstadt, Rene, et al.
Publicado: (2017)

Corrigendum to “Small-molecule inhibitors as potential therapeutics and as tools to understand the role of phospholipases A2” [Biochim. Biophys. Acta Mol. Cell Biol. Lipids 1864/6 2019 941-956]
por: Nikolaou, Aikaterini, et al.
Publicado: (2019)

Characterization of FKGK18 as Inhibitor of Group VIA Ca(2+)-Independent Phospholipase A(2) (iPLA(2)β): Candidate Drug for Preventing Beta-Cell Apoptosis and Diabetes
por: Ali, Tomader, et al.
Publicado: (2013)

Changing prostaglandin E2 (PGE(2)) signaling during lesional progression and exacerbation of endometriosis by inhibition of PGE(2) receptor EP2 and EP4
por: Huang, Qingqing, et al.
Publicado: (2021)

Study of the Royal Jelly Free Fatty Acids by Liquid Chromatography-High Resolution Mass Spectrometry (LC-HRMS)
por: Kokotou, Maroula G., et al.
Publicado: (2020)

Free Saturated Oxo Fatty Acids (SOFAs) and Ricinoleic Acid in Milk Determined by a Liquid Chromatography-High-Resolution Mass Spectrometry (LC-HRMS) Method
por: Kokotou, Maroula G., et al.
Publicado: (2021)

Design, Synthesis, and Characterization of α-Ketoheterocycles That Additionally Target the Cytosolic Port Cys269 of Fatty Acid Amide Hydrolase
por: Otrubova, Katerina, et al.
Publicado: (2014)

Prostaglandin E(2) (PGE(2)) Exerts Biphasic Effects on Human Tendon Stem Cells
por: Zhang, Jianying, et al.
Publicado: (2014)

COX-2/mPGES-1/PGE(2) cascade activation mediates uric acid-induced mesangial cell proliferation
por: Li, Shuzhen, et al.
Publicado: (2016)

The Contribution of Cytosolic Group IVA and Calcium-Independent Group VIA Phospholipase A(2)s to Adrenic Acid Mobilization in Murine Macrophages
por: Monge, Patricia, et al.
Publicado: (2020)

Highly Potent 2-Oxoester Inhibitors of Cytosolic Phospholipase A(2) (GIVA cPLA(2))
por: Psarra, Anastasia, et al.
Publicado: (2018)

Correction to “Highly Potent 2-Oxoester Inhibitors of Cytosolic Phospholipase A(2) (GIVA cPLA(2))”
por: Psarra, Anastasia, et al.
Publicado: (2019)

An Update of Microsomal Prostaglandin E Synthase-1 and PGE(2) Receptors in Cardiovascular Health and Diseases
por: Yang, Guangrui, et al.
Publicado: (2016)

Role of the prostaglandin E(2) receptor agonists in TGF-β1-induced mesangial cell damage
por: Xi, Pei-pei, et al.
Publicado: (2016)

Inhibition of Ca(2+)-Independent Phospholipase A(2)β (iPLA(2)β) Ameliorates Islet Infiltration and Incidence of Diabetes in NOD Mice
por: Bone, Robert N., et al.
Publicado: (2015)

A Liquid Chromatography-High Resolution Mass Spectrometry (LC-HRMS) Method for the Determination of Free Hydroxy Fatty Acids in Cow and Goat Milk
por: Kokotou, Maroula G., et al.
Publicado: (2020)

Pharmacological modulation of prostaglandin E(2) (PGE(2)) EP receptors improves cardiomyocyte function under hyperglycemic conditions
por: Bosma, Karin J., et al.
Publicado: (2022)

A prostaglandin E (PGE) receptor EP4 antagonist protects natural killer cells from PGE(2)-mediated immunosuppression and inhibits breast cancer metastasis
por: Ma, Xinrong, et al.
Publicado: (2013)

The role of prostaglandin E(2 )(PGE (2)) in toll-like receptor 4 (TLR4)-mediated colitis-associated neoplasia
por: Hernandez, Yasmin, et al.
Publicado: (2010)

A Vasopressin-Induced Change in Prostaglandin Receptor Subtype Expression Explains the Differential Effect of PGE(2) on AQP2 Expression
por: Deen, Peter M. T., et al.
Publicado: (2022)

Role of the prostaglandin E2/E-prostanoid 2 receptor signalling pathway in TGFβ-induced mice mesangial cell damage
por: Li, Na-Na, et al.
Publicado: (2014)

2-Oxoesters: A Novel Class of Potent and Selective Inhibitors of Cytosolic Group IVA Phospholipase A(2)
por: Kokotou, Maroula G., et al.
Publicado: (2017)

Novel link between prostaglandin E(2) (PGE(2)) and cholinergic signaling in lung cancer: The role of c-Jun in PGE(2)-induced α7 nicotinic acetylcholine receptor expression and tumor cell proliferation
por: Zhong, XiaoRong, et al.
Publicado: (2015)

Renoprotective effect of berberine via regulating the PGE (2)‐EP1‐Gαq‐Ca(2+) signalling pathway in glomerular mesangial cells of diabetic rats
por: Ni, Wei‐Jian, et al.
Publicado: (2016)

PPARβ/δ Augments IL-1β-Induced COX-2 Expression and PGE2 Biosynthesis in Human Mesangial Cells via the Activation of SIRT1
por: Li, Yaqing, et al.
Publicado: (2022)

Overview of Prostaglandin E2 (PGE2)-Targeting Radiolabelled Imaging Probes from Preclinical Perspective: Lessons Learned and Road Ahead
por: Képes, Zita, et al.
Publicado: (2023)

Prostaglandin E-Major Urinary Metabolite (PGE-MUM) as a Tumor Marker for Lung Adenocarcinoma
por: Kawamoto, Hironori, et al.
Publicado: (2019)

Upregulation of Cyclooxygenase-2/Prostaglandin E(2) (COX-2/PGE(2)) Pathway Member Multiple Drug Resistance-Associated Protein 4 (MRP4) and Downregulation of Prostaglandin Transporter (PGT) and 15-Prostaglandin Dehydrogenase (15-PGDH) in Triple-Negative Breast Cancer
por: Kochel, Tyler J., et al.
Publicado: (2016)

Prostaglandin E2 (PGE2) promotes proliferation and invasion by enhancing SUMO-1 activity via EP4 receptor in endometrial cancer
por: Ke, Jieqi, et al.
Publicado: (2016)

Role of PGE(2) in Asthma and Nonasthmatic Eosinophilic Bronchitis
por: Sastre, Beatriz, et al.
Publicado: (2012)

Lipidomics Analysis of Free Fatty Acids in Human Plasma of Healthy and Diabetic Subjects by Liquid Chromatography-High Resolution Mass Spectrometry (LC-HRMS)
por: Kokotou, Maroula G., et al.
Publicado: (2022)

Immunohistochemical Expressions of Main PGE(2) Biosynthesis-related Enzymes and PGE(2) Receptor in Rat Nephrogenesis
por: Yamamoto, Emi, et al.
Publicado: (2011)

Identification of a Dual Inhibitor of Secreted Phospholipase A(2) (GIIA sPLA(2)) and SARS-CoV-2 Main Protease
por: Theodoropoulou, Maria A., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_8sf3ocmfb25dtrn3ju9h6l8gqn